CYBERDYNE Inc. Stock

Equities

7779

JP3311530004

Healthcare Facilities & Services

Delayed Japan Exchange 02:00:00 2024-04-19 am EDT 5-day change 1st Jan Change
191 JPY -3.05% Intraday chart for CYBERDYNE Inc. -4.02% -14.73%
Sales 2024 * 4.44B 28.74M Sales 2025 * 5.28B 34.22M Capitalization 41.59B 269M
Net income 2024 * -778M -5.04M Net income 2025 * 93M 602K EV / Sales 2024 * 4.57 x
Net cash position 2024 * 21.31B 138M Net cash position 2025 * 21.11B 137M EV / Sales 2025 * 3.88 x
P/E ratio 2024 *
-54 x
P/E ratio 2025 *
438 x
Employees 257
Yield 2024 *
-
Yield 2025 *
-
Free-Float 46.92%
More Fundamentals * Assessed data
Dynamic Chart
CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization CI
Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings MT
Cyberdyne to Sign a Consignment Agreement with NEDO; Expects 332 Million Yen in Other Income for Fiscal 2023 MT
Cyeberdyne Appoints Shinji Honda as New Executive Director and COO MT
CYBERDYNE Inc. Appoints Shinji Honda as New Executive Director and Chief Operating Officer, Effective December 18, 2023 CI
Cyberdyne Books 660 million Yen in Impairment Loss in Fiscal Q2 MT
Cyberdyne Secures Grant for Development of Robotic Care Device Overseas MT
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 1-JUN-2023. CI
CYBERDYNE Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
CYBERDYNE Inc. completed the acquisition of 8% stake in LeyLine GmbH from Midori Moriwaki. CI
Cyberdyne to Take Controlling Stake in German Racing Team Operator MT
CYBERDYNE Inc. signed an agreement to acquire 8% stake in LeyLine GmbH from Midori Moriwaki. CI
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 28-FEB-2023. CI
Cyberdyne Repurchases 1.2 Billion Yen Worth of Stock; Shares Gain 4% MT
Tranche Update on CYBERDYNE Inc.'s Equity Buyback Plan announced on February 20, 2023. CI
More news
1 day-3.05%
1 week-4.02%
Current month-10.33%
1 month-14.73%
3 months-11.57%
6 months-25.97%
Current year-14.73%
More quotes
1 week
188.00
Extreme 188
203.00
1 month
188.00
Extreme 188
227.00
Current year
188.00
Extreme 188
236.00
1 year
188.00
Extreme 188
357.00
3 years
188.00
Extreme 188
671.00
5 years
188.00
Extreme 188
975.00
10 years
188.00
Extreme 188
2 629.00
More quotes
Managers TitleAgeSince
Founder 65 04-06-23
Director of Finance/CFO 54 08-08-31
Chief Operating Officer 65 Dec. 17
Members of the board TitleAgeSince
Director/Board Member 65 13-05-31
Chief Operating Officer 65 Dec. 17
Director/Board Member 74 15-05-31
More insiders
Date Price Change Volume
24-04-19 191 -3.05% 2 048 100
24-04-18 197 -0.51% 557,600
24-04-17 198 -1.00% 910,900
24-04-16 200 +0.50% 1,685,700
24-04-15 199 0.00% 749,500

Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT

More quotes
Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
197 JPY
Average target price
320 JPY
Spread / Average Target
+62.44%
Consensus